Literature DB >> 24131683

Prevalence and genotype distribution of Pneumocystis jirovecii in Cuban infants and toddlers with whooping cough.

Ernesto X Monroy-Vaca1, Yaxsier de Armas, María T Illnait-Zaragozí, Gilda Toraño, Raúl Diaz, Dania Vega, Ileana Alvarez-Lam, Enrique J Calderón, Christen R Stensvold.   

Abstract

This study describes the prevalence and genotype distribution of Pneumocystis jirovecii obtained from nasopharyngeal (NP) swabs from immunocompetent Cuban infants and toddlers with whooping cough (WC). A total of 163 NP swabs from 163 young Cuban children with WC who were admitted to the respiratory care units at two pediatric centers were studied. The prevalence of the organism was determined by a quantitative PCR (qPCR) assay targeting the P. jirovecii mitochondrial large subunit (mtLSU) rRNA gene. Genotypes were identified by direct sequencing of mtLSU ribosomal DNA (rDNA) and restriction fragment length polymorphism (RFLP) analysis of the dihydropteroate synthase (DHPS) gene amplicons. qPCR detected P. jirovecii DNA in 48/163 (29.4%) samples. mtLSU rDNA sequence analysis revealed the presence of three different genotypes in the population. Genotype 2 was most common (48%), followed in prevalence by genotypes 1 (23%) and 3 (19%); mixed-genotype infections were seen in 10% of the cases. RFLP analysis of DHPS PCR products revealed four genotypes, 18% of which were associated with resistance to sulfa drugs. Only contact with coughers (prevalence ratio [PR], 3.51 [95% confidence interval {CI}, 1.79 to 6.87]; P = 0.000) and exposure to tobacco smoke (PR, 1.82 [95% CI, 1.14 to 2.92]; P = 0.009) were statistically associated with being colonized by P. jirovecii. The prevalence of P. jirovecii in infants and toddlers with WC and the genotyping results provide evidence that this population represents a potential reservoir and transmission source of P. jirovecii.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24131683      PMCID: PMC3911444          DOI: 10.1128/JCM.02381-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations.

Authors:  O Matos; F Esteves
Journal:  Parasite       Date:  2010-09       Impact factor: 3.000

2.  Geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations within Western Europe.

Authors:  Meja Rabodonirina; Aimable Nahimana; Rainer Weber; Patrick Francioli; Jacques Bille; Philippe M Hauser
Journal:  J Eukaryot Microbiol       Date:  2006       Impact factor: 3.346

3.  Pneumocystis carinii organisms derived from rat and human hosts are genetically distinct.

Authors:  K Sinclair; A E Wakefield; S Banerji; J M Hopkin
Journal:  Mol Biochem Parasitol       Date:  1991-03       Impact factor: 1.759

4.  Dihydropteroate synthase polymorphisms in Pneumocystis carinii.

Authors:  B R Lane; J C Ast; P A Hossler; D P Mindell; M S Bartlett; J W Smith; S R Meshnick
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

Review 5.  Pneumocystis: not just pneumonia.

Authors:  J Chad Peterson; Melanie T Cushion
Journal:  Curr Opin Microbiol       Date:  2005-08       Impact factor: 7.934

6.  Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.

Authors:  T R Navin; C B Beard; L Huang; C del Rio; S Lee; N J Pieniazek; J L Carter; T Le; A Hightower; D Rimland
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

7.  Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.

Authors:  P Kazanjian; W Armstrong; P A Hossler; W Burman; J Richardson; C H Lee; L Crane; J Katz; S R Meshnick
Journal:  J Infect Dis       Date:  2000-07-28       Impact factor: 5.226

8.  Clinical relevance of multiple single-nucleotide polymorphisms in Pneumocystis jirovecii Pneumonia: development of a multiplex PCR-single-base-extension methodology.

Authors:  F Esteves; J Gaspar; B De Sousa; F Antunes; K Mansinho; O Matos
Journal:  J Clin Microbiol       Date:  2011-03-09       Impact factor: 5.948

9.  Pneumocystis jiroveci genotypes in the Spanish population.

Authors:  M A Montes-Cano; C de la Horra; J Martin-Juan; J M Varela; R Torronteras; N Respaldiza; F J Medrano; E J Calderón
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

10.  Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain.

Authors:  F Esteves; M A Montes-Cano; C de la Horra; M C Costa; E J Calderón; F Antunes; O Matos
Journal:  Clin Microbiol Infect       Date:  2008-02-02       Impact factor: 8.067

View more
  8 in total

1.  High transient colonization by Pneumocystis jirovecii between mothers and newborn.

Authors:  Cristian Vera; Yudy A Aguilar; Lázaro A Vélez; Zulma Vanessa Rueda
Journal:  Eur J Pediatr       Date:  2017-09-14       Impact factor: 3.183

2.  Evaluation of the Amplex eazyplex Loop-Mediated Isothermal Amplification Assay for Rapid Diagnosis of Pneumocystis jirovecii Pneumonia.

Authors:  Timo Huber; Annerose Serr; Walter Geißdörfer; Christina Hess; Christian Lynker-Aßmus; Friederike D von Loewenich; Christian Bogdan; Jürgen Held
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

3.  Epidemiological Outbreaks of Pneumocystis jirovecii Pneumonia Are Not Limited to Kidney Transplant Recipients: Genotyping Confirms Common Source of Transmission in a Liver Transplantation Unit.

Authors:  Guillaume Desoubeaux; Manon Dominique; Florent Morio; Rose-Anne Thepault; Claire Franck-Martel; Anne-Charlotte Tellier; Martine Ferrandière; Christophe Hennequin; Louis Bernard; Ephrem Salamé; Éric Bailly; Jacques Chandenier
Journal:  J Clin Microbiol       Date:  2016-03-02       Impact factor: 5.948

Review 4.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

5.  First data on Pneumocystis jirovecii colonization in patients with respiratory diseases in North Lebanon.

Authors:  S Khalife; E M Aliouat; C M Aliouat-Denis; N Gantois; P Devos; H Mallat; E Dei-Cas; F Dabboussi; M Hamze; E Fréalle
Journal:  New Microbes New Infect       Date:  2015-03-04

6.  Molecular diagnosis and genotyping of Pneumocystis jirovecii in bronchoalveolar lavage samples obtained from patients with pulmonary disorder.

Authors:  Abdolmajid Fata; Bahareh Abdollahi; Fariba Rezaeetalab; Davood Attaran; Mohsen Najjari; Mohammad J Najafzadeh
Journal:  Curr Med Mycol       Date:  2019-09

Review 7.  Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals.

Authors:  Francesca Gioia; Hanan Albasata; Seyed M Hosseini-Moghaddam
Journal:  J Fungi (Basel)       Date:  2022-05-30

8.  Diagnosis of the primary infection by pneumocystis in autopsy specimens from two infants using lung impression smears (touch preps).

Authors:  Carolina A Ponce; Rebeca I Bustamante; Myriam Gallo; Sergio L Vargas
Journal:  Med Mycol Case Rep       Date:  2014-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.